Back to Trades
Jorgensen Nathan D.
Chief Financial OfficerCIK 0001842523
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2025–2026
Across 2 filings between 2025–2026, Jorgensen Nathan D., Chief Financial Officer, has disclosed $54.2K in transactions — all concentrated in Voyager Therapeutics, Inc. (VYGR). Their disclosed trades are heavily weighted toward selling — $0 in buys and $54.2K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Feb 26 | VYGR Voyager Therapeutics, Inc. | Jorgensen Nathan D. | Chief Financial Officer | Sell | $17.6K |
| Oct 7 | VYGR Voyager Therapeutics, Inc. | Jorgensen Nathan D. | Chief Financial Officer | Sell | $36.6K |
2 filings